JPMorgan Chase & Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by JPMorgan Chase & Co. on June 27, 2007. The filing serves to incorporate specific tax opinions by reference into the company's Registration Statement on Form S-3ASR (File No. 333-130051).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is an administrative filing regarding exhibits and does not contain financial performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely lists the submission of three tax opinions as exhibits.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, or outlook. The exhibits relate to tax opinions for specific structured notes:
- Principal Protected Notes linked to a basket of seven commodities and the Euro/USD exchange rate (due June 30, 2011).
- 5.25% Reverse Exchangeable Notes linked to Bowater Incorporated common stock (due October 2, 2007).
- 5.0% Reverse Exchangeable Notes linked to Pfizer Inc. common stock (due December 28, 2007).
Key Facts for Investor Verification
- Verify the terms and risks of the structured notes described in Exhibits 8.1, 8.2, and 8.3 within the referenced Form S-3ASR.
- Confirm the tax implications of the Principal Protected Notes and Reverse Exchangeable Notes as outlined by Davis Polk & Wardwell.
- Note that this filing does not contain quarterly or annual financial results.